Trial intelligence / Profile preview

Pulsed actinomycin versus 5-day methotrexate in low-risk gestational trophoblastic neoplasm

IRCT2015012519567N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of actinomycin D and methotrexate in trophoblastic tumour (2 arms), sponsored by Tehran University of Medical Sciences. Started Mar 2011; status: completed.

02

Drugs

actinomycin Dmethotrexate
03

Conditions

trophoblastic tumour

Beyond the preview

Go deeper on IRCT2015012519567N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015012519567N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call